MAPT and Alzheimer disease: Alzheimer’s disease (AD) is clinically characterized as progressive dementia with the pathological hallmarks of senile plaques and neurofibrillary tangles comprising amyloid-β peptide (Aβ) and hyperphosphorylated tau (p-tau), respectively.